NovaBay Pharmaceuticals, Inc. Long-Term Investments

Long-Term Investments of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-Term Investments growth rates and interactive chart. An accounting item that represents the company's investments, including stocks, bonds, real estate, and cash. Long-term investments are assets that a company intends to hold for more than a year. The long-term investment account differs largely from the short-term investment account in that short-term investments will most likely be sold, whereas the long-term investments will not be sold for years and, in some cases, may never be sold.


Highlights and Quick Summary

  • Long-Term Investments for the quarter ending June 30, 2022 was $155 Thousand (a 1.97% increase compared to previous quarter)
  • Year-over-year quarterly Long-Term Investments decreased by -67.37%
  • Annual Long-Term Investments for 2021 was $475 Thousand (a 0.0% decrease from previous year)
  • Annual Long-Term Investments for 2020 was $475 Thousand (a 0.0% decrease from previous year)
  • Annual Long-Term Investments for 2019 was $475 Thousand (a 0.0% decrease from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-Term Investments of NovaBay Pharmaceuticals, Inc.

Most recent Long-Term Investmentsof NBY including historical data for past 10 years.

Interactive Chart of Long-Term Investments of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Long-Term Investments for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.16 $0.15
2021 $0.48 $0.48 $0.48 $0.48 $0.48
2020 $0.48 $0.48 $0.48 $0.48 $0.48
2019 $0.48 $0.48
2018 $0.48

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology